Search Results - "Buckingham, Bruce"

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range by Battelino, Tadej, Danne, Thomas, Bergenstal, Richard M, Amiel, Stephanie A, Beck, Roy, Biester, Torben, Bosi, Emanuele, Buckingham, Bruce A, Cefalu, William T, Close, Kelly L, Cobelli, Claudio, Dassau, Eyal, DeVries, J Hans, Donaghue, Kim C, Dovc, Klemen, Doyle, 3rd, Francis J, Garg, Satish, Grunberger, George, Heller, Simon, Heinemann, Lutz, Hirsch, Irl B, Hovorka, Roman, Jia, Weiping, Kordonouri, Olga, Kovatchev, Boris, Kowalski, Aaron, Laffel, Lori, Levine, Brian, Mayorov, Alexander, Mathieu, Chantal, Murphy, Helen R, Nimri, Revital, Nørgaard, Kirsten, Parkin, Christopher G, Renard, Eric, Rodbard, David, Saboo, Banshi, Schatz, Desmond, Stoner, Keaton, Urakami, Tatsuiko, Weinzimer, Stuart A, Phillip, Moshe

“…Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous glucose monitoring…”
Get full text

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes by Breton, Marc D, Kanapka, Lauren G, Beck, Roy W, Ekhlaspour, Laya, Forlenza, Gregory P, Cengiz, Eda, Schoelwer, Melissa, Ruedy, Katrina J, Jost, Emily, Carria, Lori, Emory, Emma, Hsu, Liana J, Oliveri, Mary, Kollman, Craig C, Dokken, Betsy B, Weinzimer, Stuart A, DeBoer, Mark D, Buckingham, Bruce A, Cherñavvsky, Daniel, Wadwa, R. Paul

“…A closed-loop system (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes. In this 16-week trial, the glucose…”
Get full text

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes by Brown, Sue A, Kovatchev, Boris P, Raghinaru, Dan, Lum, John W, Buckingham, Bruce A, Kudva, Yogish C, Laffel, Lori M, Levy, Carol J, Pinsker, Jordan E, Wadwa, R. Paul, Dassau, Eyal, Doyle, Francis J, Anderson, Stacey M, Church, Mei Mei, Dadlani, Vikash, Ekhlaspour, Laya, Forlenza, Gregory P, Isganaitis, Elvira, Lam, David W, Kollman, Craig, Beck, Roy W

“…Closed-loop systems that automate insulin delivery may improve glycemic outcomes in patients with type 1 diabetes. In this 6-month randomized, multicenter…”
Get full text

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes by Bergenstal, Richard M, Garg, Satish, Weinzimer, Stuart A, Buckingham, Bruce A, Bode, Bruce W, Tamborlane, William V, Kaufman, Francine R

Get full text

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement by Battelino, Tadej, Alexander, Charles M, Amiel, Stephanie A, Arreaza-Rubin, Guillermo, Beck, Roy W, Bergenstal, Richard M, Buckingham, Bruce A, Carroll, James, Ceriello, Antonio, Chow, Elaine, Choudhary, Pratik, Close, Kelly, Danne, Thomas, Dutta, Sanjoy, Gabbay, Robert, Garg, Satish, Heverly, Julie, Hirsch, Irl B, Kader, Tina, Kenney, Julia, Kovatchev, Boris, Laffel, Lori, Maahs, David, Mathieu, Chantal, Mauricio, Dídac, Nimri, Revital, Nishimura, Rimei, Scharf, Mauro, Del Prato, Stefano, Renard, Eric, Rosenstock, Julio, Saboo, Banshi, Ueki, Kohjiro, Umpierrez, Guillermo E, Weinzimer, Stuart A, Phillip, Moshe

“…Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA1c…”
Get full text

925-P: Postprandial Glucose Control Using an Extended Bolus for High Fat High Protein (HFHP) Meals during Closed-Loop (CL) in Patients with Type 1 Diabetes (T1D) by EKHLASPOUR, LAYA, HOSSEINIPOUR, YASAMAN J., BUCKINGHAM, BRUCE A., CENGIZ, EDA

“…We investigated the impact of an extended bolus (EB) for a HFHP breakfast on postprandial glycemia in adolescents with T1D using the Control IQ (CIQ) system…”
Get full text

International Consensus on Use of Continuous Glucose Monitoring by Danne, Thomas, Nimri, Revital, Battelino, Tadej, Bergenstal, Richard M, Close, Kelly L, DeVries, J Hans, Garg, Satish, Heinemann, Lutz, Hirsch, Irl, Amiel, Stephanie A, Beck, Roy, Bosi, Emanuele, Buckingham, Bruce, Cobelli, Claudio, Dassau, Eyal, Doyle, 3rd, Francis J, Heller, Simon, Hovorka, Roman, Jia, Weiping, Jones, Tim, Kordonouri, Olga, Kovatchev, Boris, Kowalski, Aaron, Laffel, Lori, Maahs, David, Murphy, Helen R, Nørgaard, Kirsten, Parkin, Christopher G, Renard, Eric, Saboo, Banshi, Scharf, Mauro, Tamborlane, William V, Weinzimer, Stuart A, Phillip, Moshe

“…Measurement of glycated hemoglobin (HbA ) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday…”
Get full text

Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes by Wadwa, R. Paul, Reed, Zachariah W., Buckingham, Bruce A., DeBoer, Mark D., Ekhlaspour, Laya, Forlenza, Gregory P., Schoelwer, Melissa, Lum, John, Kollman, Craig, Beck, Roy W., Breton, Marc D.

“…In children 2 to younger than 6 years of age with type 1 diabetes, a closed-loop control system was associated with a greater percentage of time in the target…”
Get full text

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System by Messer, Laurel H, Forlenza, Gregory P, Sherr, Jennifer L, Wadwa, R Paul, Buckingham, Bruce A, Weinzimer, Stuart A, Maahs, David M, Slover, Robert H

“…The MiniMed 670G System is the first commercial hybrid closed-loop (HCL) system for management of type 1 diabetes. Using data from adolescent and young adult…”
Get full text

Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial by Forlenza, Gregory P, Li, Zoey, Buckingham, Bruce A, Pinsker, Jordan E, Cengiz, Eda, Wadwa, R Paul, Ekhlaspour, Laya, Church, Mei Mei, Weinzimer, Stuart A, Jost, Emily, Marcal, Tatiana, Andre, Camille, Carria, Lori, Swanson, Vance, Lum, John W, Kollman, Craig, Woodall, William, Beck, Roy W

“…This study evaluated a new insulin delivery system designed to reduce insulin delivery when trends in continuous glucose monitoring (CGM) glucose…”
Get full text

1359-P: Effect of Fat Content on Postprandial Gastric Retention and Glucose Absorption in Subjects with Type 1 Diabetes during Daily Life Conditions: Assessment through a Computational Model by FAGGIONATO, EDOARDO, SCHIAVON, MICHELE, BUCKINGHAM, BRUCE A., EKHLASPOUR, LAYA, MAN, CHIARA DALLA

“…Understanding the impact of dietary nutrients on postprandial gastric retention (GR) and glucose absorption (GA) is crucial for optimizing both open- and…”
Get full text

Decreasing the Burden of Carbohydrate Counting and Meal Announcement with Automated Insulin Delivery, Meal Recognition, and Autocorrection Doses: A Case Study by Buckingham, Bruce A, Bergenstal, Richard M

“…The use of automated insulin delivery (AID) has led to a decrease in the burden of diabetes, allowing for better sleep, decreased anxiety about hypoglycemia,…”
Get more information

Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR by Cortez, Felipe de Jesus, Gebhart, David, Robinson, Peter V, Seftel, David, Pourmandi, Narges, Owyoung, Jordan, Bertozzi, Carolyn R, Wilson, Darrell M, Maahs, David M, Buckingham, Bruce A, Mills, John R, Roforth, Matthew M, Pittock, Sean J, McKeon, Andrew, Page, Kara, Wolf, Wendy A, Sanda, Srinath, Speake, Cate, Greenbaum, Carla J, Tsai, Cheng-Ting

“…Islet autoantibodies are predominantly measured by radioassay to facilitate risk assessment and diagnosis of type 1 diabetes. However, the reliance on…”
Get full text

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes by Brown, Sue A, Forlenza, Gregory P, Bode, Bruce W, Pinsker, Jordan E, Levy, Carol J, Criego, Amy B, Hansen, David W, Hirsch, Irl B, Carlson, Anders L, Bergenstal, Richard M, Sherr, Jennifer L, Mehta, Sanjeev N, Laffel, Lori M, Shah, Viral N, Bhargava, Anuj, Weinstock, Ruth S, MacLeish, Sarah A, DeSalvo, Daniel J, Jones, Thomas C, Aleppo, Grazia, Buckingham, Bruce A, Ly, Trang T

“…Advances in diabetes technology have transformed the treatment paradigm for type 1 diabetes, yet the burden of disease is significant. We report on a pivotal…”
Get full text

Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop Trial by Ekhlaspour, Laya, Town, Marissa, Raghinaru, Dan, Lum, John W, Brown, Sue A, Buckingham, Bruce A

“…Using a closed-loop system significantly improves time in range (TIR) 70-180 mg/dL in patients with type 1 diabetes (T1D). In a 6-month RCT, 112 subjects were…”
Get more information

116-LB: New Insulin-to-Carb Ratio Formulas for Hybrid Closed-Loop Pump Use by TABATABAI, IDEEN, BUCKINGHAM, BRUCE A.

“…Objective: Formulas to determine Insulin-Carbohydrate Ratio (ICR) use total daily dose (TDD) such as the 450 Rule (450/TDD=ICR) or body weight (BW) (2.8*weight…”
Get full text

Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial by Isganaitis, Elvira, Raghinaru, Dan, Ambler-Osborn, Louise, Pinsker, Jordan E, Buckingham, Bruce A, Wadwa, R Paul, Ekhlaspour, Laya, Kudva, Yogish C, Levy, Carol J, Forlenza, Gregory P, Beck, Roy W, Kollman, Craig, Lum, John W, Brown, Sue A, Laffel, Lori M

“…To assess the efficacy and safety of closed-loop control (CLC) insulin delivery system in adolescents and young adults with type 1 diabetes. Prespecified…”
Get more information

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes by Garg, Satish K, Weinzimer, Stuart A, Tamborlane, William V, Buckingham, Bruce A, Bode, Bruce W, Bailey, Timothy S, Brazg, Ronald L, Ilany, Jacob, Slover, Robert H, Anderson, Stacey M, Bergenstal, Richard M, Grosman, Benyamin, Roy, Anirban, Cordero, Toni L, Shin, John, Lee, Scott W, Kaufman, Francine R

“…The safety and effectiveness of the in-home use of a hybrid closed-loop (HCL) system that automatically increases, decreases, and suspends insulin delivery in…”
Get more information

Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp by Ly, Trang T, Roy, Anirban, Grosman, Benyamin, Shin, John, Campbell, Alex, Monirabbasi, Salman, Liang, Bradley, von Eyben, Rie, Shanmugham, Satya, Clinton, Paula, Buckingham, Bruce A

“…To evaluate the feasibility and efficacy of a fully integrated hybrid closed-loop (HCL) system (Medtronic MiniMed Inc., Northridge, CA), in day and night…”
Get full text

A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72 by Beck, Roy W, Kanapka, Lauren G, Breton, Marc D, Brown, Sue A, Wadwa, R Paul, Buckingham, Bruce A, Kollman, Craig, Kovatchev, Boris

“…To evaluate the effect of hybrid-closed loop Control-IQ technology (Control-IQ) in randomized controlled trials (RCTs) in subgroups based on baseline…”
Get more information